112. Thalassemia and Globin Gene Regulation: Poster I

FGF23 Inhibition Improves Hematopoietic Stem Cell Transplantation in ß-Thalassemia

Identifying Novel Regulators of ?-Globin Expression Using a Genome-Scale CRISPR Activation Screen

Genome-Scale CRISPR-Cas12a Screen Identifies Novel Fetal Hemoglobin Regulators

Sustained Efficacy, Safety, and Improved Quality of Life in Adult and Pediatric Patients with Transfusion-Dependent ß-Thalassemia up to 9 Years Post T

Evolving Changes in the Characteristics of Death in Transfusion Dependent Thalassemia in Greece

Improvement of Underlying Disease Pathophysiology of Ineffective Erythropoiesis in Non-Transfusion-Dependent (NTD) Patients with ß-Thalassemia Receivi

A Novel Beta Globin Frameshift Mutation Causing Autosomal Dominant Beta Thalassemia

NR2F1 : A Novel Candidate for Gamma Globin Activation

Delineating the Functions of Cohesin Stag1 during Terminal Erythroid Differentiation